0.013053
0.007536
0.000000
0.000000
0.015073
0.000000
0.000000
0.000000
0.007418
0.000000
0.000000
0.000000
Joint Center for Structural Genomics (JCSG)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
6
90.000
90.000
120.000
76.609
76.609
134.815
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C2 H6 O2
62.068
1,2-ETHANEDIOL
ETHYLENE GLYCOL
non-polymer
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be published
0353
Crystal structure of Putative methyltransferase from antibiotic biosynthesis pathway (YP_324569.1) from ANABAENA VARIABILIS ATCC 29413 at 2.40 A resolution
10.2210/pdb3ege/pdb
pdb_00003ege
100
1
Flat collimating mirror, toroid focusing mirror
CCD
2008-08-11
MARMOSAIC 325 mm CCD
Double crystal monochromator
SINGLE WAVELENGTH
M
x-ray
1
0.97915
1.0
BL9-2
SSRL
0.97915
SYNCHROTRON
SSRL BEAMLINE BL9-2
29883.744
Putative methyltransferase from antibiotic biosynthesis pathway
1
man
polymer
62.068
1,2-ETHANEDIOL
1
syn
non-polymer
18.015
water
124
nat
water
Putative MerR-family transcriptional regulator
no
yes
G(MSE)SIYNSIGKQYSQTRVPDIRIVNAIINLLNLPKGSVIADIGAGTGGYSVALANQGLFVYAVEPSIV(MSE)RQQA
VVHPQVEWFTGYAENLALPDKSVDGVISILAIHHFSHLEKSFQE(MSE)QRIIRDGTIVLLTFDIRLAQRIWLYDYFPFL
WEDALRFLPLDEQINLLQENTKRRVEAIPFLLPHDLSDLFAAAAWRRPELYLKAEVRAGISSFALANQDLVEKGLELLTA
DLNNGEWIRKYGEIHHLQEIDIGYRFIYTTLDK
GMSIYNSIGKQYSQTRVPDIRIVNAIINLLNLPKGSVIADIGAGTGGYSVALANQGLFVYAVEPSIVMRQQAVVHPQVEW
FTGYAENLALPDKSVDGVISILAIHHFSHLEKSFQEMQRIIRDGTIVLLTFDIRLAQRIWLYDYFPFLWEDALRFLPLDE
QINLLQENTKRRVEAIPFLLPHDLSDLFAAAAWRRPELYLKAEVRAGISSFALANQDLVEKGLELLTADLNNGEWIRKYG
EIHHLQEIDIGYRFIYTTLDK
A
383250
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
29413
YP_324569.1, Ava_4070
240292
Anabaena variabilis ATCC 29413
562
Escherichia coli
HK100
Plasmid
SpeedET
1
3.82
67.81
VAPOR DIFFUSION, SITTING DROP
4.2
31.0% ethylene glycol, 0.1M phosphate-citrate pH 4.2, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
277
Joint Center for Structural Genomics
JCSG
PSI, Protein Structure Initiative
software
software
struct_conn
database_2
struct_ref_seq_dif
struct_site
repository
Initial release
Advisory
Version format compliance
Refinement description
Data collection
Derived calculations
Refinement description
Database references
Derived calculations
1
0
2008-10-14
1
1
2011-07-13
1
2
2017-10-25
1
3
2019-07-24
1
4
2023-02-01
_software.classification
_software.name
_software.classification
_software.contact_author
_software.contact_author_email
_software.language
_software.location
_software.name
_software.type
_software.version
_struct_conn.pdbx_leaving_atom_flag
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
RCSB
Y
RCSB
2008-09-10
REL
REL
EDO
1,2-ETHANEDIOL
HOH
water
THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
EDO
1
2
EDO
EDO
261
A
HOH
2
3
HOH
HOH
262
A
HOH
3
3
HOH
HOH
263
A
HOH
4
3
HOH
HOH
264
A
HOH
5
3
HOH
HOH
265
A
HOH
6
3
HOH
HOH
266
A
HOH
7
3
HOH
HOH
267
A
HOH
8
3
HOH
HOH
268
A
HOH
9
3
HOH
HOH
269
A
HOH
10
3
HOH
HOH
270
A
HOH
11
3
HOH
HOH
271
A
HOH
12
3
HOH
HOH
272
A
HOH
13
3
HOH
HOH
273
A
HOH
14
3
HOH
HOH
274
A
HOH
15
3
HOH
HOH
275
A
HOH
16
3
HOH
HOH
276
A
HOH
17
3
HOH
HOH
277
A
HOH
18
3
HOH
HOH
278
A
HOH
19
3
HOH
HOH
279
A
HOH
20
3
HOH
HOH
280
A
HOH
21
3
HOH
HOH
281
A
HOH
22
3
HOH
HOH
282
A
HOH
23
3
HOH
HOH
283
A
HOH
24
3
HOH
HOH
284
A
HOH
25
3
HOH
HOH
285
A
HOH
26
3
HOH
HOH
286
A
HOH
27
3
HOH
HOH
287
A
HOH
28
3
HOH
HOH
288
A
HOH
29
3
HOH
HOH
289
A
HOH
30
3
HOH
HOH
290
A
HOH
31
3
HOH
HOH
291
A
HOH
32
3
HOH
HOH
292
A
HOH
33
3
HOH
HOH
293
A
HOH
34
3
HOH
HOH
294
A
HOH
35
3
HOH
HOH
295
A
HOH
36
3
HOH
HOH
296
A
HOH
37
3
HOH
HOH
297
A
HOH
38
3
HOH
HOH
298
A
HOH
39
3
HOH
HOH
299
A
HOH
40
3
HOH
HOH
300
A
HOH
41
3
HOH
HOH
301
A
HOH
42
3
HOH
HOH
302
A
HOH
43
3
HOH
HOH
303
A
HOH
44
3
HOH
HOH
304
A
HOH
45
3
HOH
HOH
305
A
HOH
46
3
HOH
HOH
306
A
HOH
47
3
HOH
HOH
307
A
HOH
48
3
HOH
HOH
308
A
HOH
49
3
HOH
HOH
309
A
HOH
50
3
HOH
HOH
310
A
HOH
51
3
HOH
HOH
311
A
HOH
52
3
HOH
HOH
312
A
HOH
53
3
HOH
HOH
313
A
HOH
54
3
HOH
HOH
314
A
HOH
55
3
HOH
HOH
315
A
HOH
56
3
HOH
HOH
316
A
HOH
57
3
HOH
HOH
317
A
HOH
58
3
HOH
HOH
318
A
HOH
59
3
HOH
HOH
319
A
HOH
60
3
HOH
HOH
320
A
HOH
61
3
HOH
HOH
321
A
HOH
62
3
HOH
HOH
322
A
HOH
63
3
HOH
HOH
323
A
HOH
64
3
HOH
HOH
324
A
HOH
65
3
HOH
HOH
325
A
HOH
66
3
HOH
HOH
326
A
HOH
67
3
HOH
HOH
327
A
HOH
68
3
HOH
HOH
328
A
HOH
69
3
HOH
HOH
329
A
HOH
70
3
HOH
HOH
330
A
HOH
71
3
HOH
HOH
331
A
HOH
72
3
HOH
HOH
332
A
HOH
73
3
HOH
HOH
333
A
HOH
74
3
HOH
HOH
334
A
HOH
75
3
HOH
HOH
335
A
HOH
76
3
HOH
HOH
336
A
HOH
77
3
HOH
HOH
337
A
HOH
78
3
HOH
HOH
338
A
HOH
79
3
HOH
HOH
339
A
HOH
80
3
HOH
HOH
340
A
HOH
81
3
HOH
HOH
341
A
HOH
82
3
HOH
HOH
342
A
HOH
83
3
HOH
HOH
343
A
HOH
84
3
HOH
HOH
344
A
HOH
85
3
HOH
HOH
345
A
HOH
86
3
HOH
HOH
346
A
HOH
87
3
HOH
HOH
347
A
HOH
88
3
HOH
HOH
348
A
HOH
89
3
HOH
HOH
349
A
HOH
90
3
HOH
HOH
350
A
HOH
91
3
HOH
HOH
351
A
HOH
92
3
HOH
HOH
352
A
HOH
93
3
HOH
HOH
353
A
HOH
94
3
HOH
HOH
354
A
HOH
95
3
HOH
HOH
355
A
HOH
96
3
HOH
HOH
356
A
HOH
97
3
HOH
HOH
357
A
HOH
98
3
HOH
HOH
358
A
HOH
99
3
HOH
HOH
359
A
HOH
100
3
HOH
HOH
360
A
HOH
101
3
HOH
HOH
361
A
HOH
102
3
HOH
HOH
362
A
HOH
103
3
HOH
HOH
363
A
HOH
104
3
HOH
HOH
364
A
HOH
105
3
HOH
HOH
365
A
HOH
106
3
HOH
HOH
366
A
HOH
107
3
HOH
HOH
367
A
HOH
108
3
HOH
HOH
368
A
HOH
109
3
HOH
HOH
369
A
HOH
110
3
HOH
HOH
370
A
HOH
111
3
HOH
HOH
371
A
HOH
112
3
HOH
HOH
372
A
HOH
113
3
HOH
HOH
373
A
HOH
114
3
HOH
HOH
374
A
HOH
115
3
HOH
HOH
375
A
HOH
116
3
HOH
HOH
376
A
HOH
117
3
HOH
HOH
377
A
HOH
118
3
HOH
HOH
378
A
HOH
119
3
HOH
HOH
379
A
HOH
120
3
HOH
HOH
380
A
HOH
121
3
HOH
HOH
381
A
HOH
122
3
HOH
HOH
382
A
HOH
123
3
HOH
HOH
383
A
HOH
124
3
HOH
HOH
384
A
HOH
125
3
HOH
HOH
385
A
n
1
0
A
n
2
1
A
n
3
2
A
n
4
3
A
n
5
4
A
n
6
5
A
n
7
6
A
n
8
7
A
n
9
8
A
n
10
9
A
n
11
10
A
n
12
11
A
SER
12
n
13
SER
12
A
GLN
13
n
14
GLN
13
A
THR
14
n
15
THR
14
A
ARG
15
n
16
ARG
15
A
VAL
16
n
17
VAL
16
A
PRO
17
n
18
PRO
17
A
ASP
18
n
19
ASP
18
A
ILE
19
n
20
ILE
19
A
ARG
20
n
21
ARG
20
A
ILE
21
n
22
ILE
21
A
VAL
22
n
23
VAL
22
A
ASN
23
n
24
ASN
23
A
ALA
24
n
25
ALA
24
A
ILE
25
n
26
ILE
25
A
ILE
26
n
27
ILE
26
A
ASN
27
n
28
ASN
27
A
LEU
28
n
29
LEU
28
A
LEU
29
n
30
LEU
29
A
ASN
30
n
31
ASN
30
A
LEU
31
n
32
LEU
31
A
PRO
32
n
33
PRO
32
A
LYS
33
n
34
LYS
33
A
GLY
34
n
35
GLY
34
A
SER
35
n
36
SER
35
A
VAL
36
n
37
VAL
36
A
ILE
37
n
38
ILE
37
A
ALA
38
n
39
ALA
38
A
ASP
39
n
40
ASP
39
A
ILE
40
n
41
ILE
40
A
GLY
41
n
42
GLY
41
A
ALA
42
n
43
ALA
42
A
GLY
43
n
44
GLY
43
A
THR
44
n
45
THR
44
A
GLY
45
n
46
GLY
45
A
GLY
46
n
47
GLY
46
A
TYR
47
n
48
TYR
47
A
SER
48
n
49
SER
48
A
VAL
49
n
50
VAL
49
A
ALA
50
n
51
ALA
50
A
LEU
51
n
52
LEU
51
A
ALA
52
n
53
ALA
52
A
ASN
53
n
54
ASN
53
A
GLN
54
n
55
GLN
54
A
GLY
55
n
56
GLY
55
A
LEU
56
n
57
LEU
56
A
PHE
57
n
58
PHE
57
A
VAL
58
n
59
VAL
58
A
TYR
59
n
60
TYR
59
A
ALA
60
n
61
ALA
60
A
VAL
61
n
62
VAL
61
A
GLU
62
n
63
GLU
62
A
PRO
63
n
64
PRO
63
A
SER
64
n
65
SER
64
A
ILE
65
n
66
ILE
65
A
VAL
66
n
67
VAL
66
A
MSE
67
n
68
MSE
67
A
ARG
68
n
69
ARG
68
A
GLN
69
n
70
GLN
69
A
GLN
70
n
71
GLN
70
A
ALA
71
n
72
ALA
71
A
VAL
72
n
73
VAL
72
A
VAL
73
n
74
VAL
73
A
HIS
74
n
75
HIS
74
A
PRO
75
n
76
PRO
75
A
GLN
76
n
77
GLN
76
A
VAL
77
n
78
VAL
77
A
GLU
78
n
79
GLU
78
A
TRP
79
n
80
TRP
79
A
PHE
80
n
81
PHE
80
A
THR
81
n
82
THR
81
A
GLY
82
n
83
GLY
82
A
TYR
83
n
84
TYR
83
A
ALA
84
n
85
ALA
84
A
GLU
85
n
86
GLU
85
A
ASN
86
n
87
ASN
86
A
LEU
87
n
88
LEU
87
A
ALA
88
n
89
ALA
88
A
LEU
89
n
90
LEU
89
A
PRO
90
n
91
PRO
90
A
ASP
91
n
92
ASP
91
A
LYS
92
n
93
LYS
92
A
SER
93
n
94
SER
93
A
VAL
94
n
95
VAL
94
A
ASP
95
n
96
ASP
95
A
GLY
96
n
97
GLY
96
A
VAL
97
n
98
VAL
97
A
ILE
98
n
99
ILE
98
A
SER
99
n
100
SER
99
A
ILE
100
n
101
ILE
100
A
LEU
101
n
102
LEU
101
A
ALA
102
n
103
ALA
102
A
ILE
103
n
104
ILE
103
A
HIS
104
n
105
HIS
104
A
HIS
105
n
106
HIS
105
A
PHE
106
n
107
PHE
106
A
SER
107
n
108
SER
107
A
HIS
108
n
109
HIS
108
A
LEU
109
n
110
LEU
109
A
GLU
110
n
111
GLU
110
A
LYS
111
n
112
LYS
111
A
SER
112
n
113
SER
112
A
PHE
113
n
114
PHE
113
A
GLN
114
n
115
GLN
114
A
GLU
115
n
116
GLU
115
A
MSE
116
n
117
MSE
116
A
GLN
117
n
118
GLN
117
A
ARG
118
n
119
ARG
118
A
ILE
119
n
120
ILE
119
A
ILE
120
n
121
ILE
120
A
ARG
121
n
122
ARG
121
A
ASP
122
n
123
ASP
122
A
GLY
123
n
124
GLY
123
A
THR
124
n
125
THR
124
A
ILE
125
n
126
ILE
125
A
VAL
126
n
127
VAL
126
A
LEU
127
n
128
LEU
127
A
LEU
128
n
129
LEU
128
A
THR
129
n
130
THR
129
A
PHE
130
n
131
PHE
130
A
ASP
131
n
132
ASP
131
A
ILE
132
n
133
ILE
132
A
ARG
133
n
134
ARG
133
A
LEU
134
n
135
LEU
134
A
ALA
135
n
136
ALA
135
A
GLN
136
n
137
GLN
136
A
ARG
137
n
138
ARG
137
A
ILE
138
n
139
ILE
138
A
TRP
139
n
140
TRP
139
A
LEU
140
n
141
LEU
140
A
TYR
141
n
142
TYR
141
A
ASP
142
n
143
ASP
142
A
TYR
143
n
144
TYR
143
A
PHE
144
n
145
PHE
144
A
PRO
145
n
146
PRO
145
A
PHE
146
n
147
PHE
146
A
LEU
147
n
148
LEU
147
A
TRP
148
n
149
TRP
148
A
GLU
149
n
150
GLU
149
A
ASP
150
n
151
ASP
150
A
ALA
151
n
152
ALA
151
A
LEU
152
n
153
LEU
152
A
ARG
153
n
154
ARG
153
A
PHE
154
n
155
PHE
154
A
LEU
155
n
156
LEU
155
A
PRO
156
n
157
PRO
156
A
LEU
157
n
158
LEU
157
A
ASP
158
n
159
ASP
158
A
GLU
159
n
160
GLU
159
A
GLN
160
n
161
GLN
160
A
ILE
161
n
162
ILE
161
A
ASN
162
n
163
ASN
162
A
LEU
163
n
164
LEU
163
A
LEU
164
n
165
LEU
164
A
GLN
165
n
166
GLN
165
A
GLU
166
n
167
GLU
166
A
ASN
167
n
168
ASN
167
A
THR
168
n
169
THR
168
A
LYS
169
n
170
LYS
169
A
ARG
170
n
171
ARG
170
A
ARG
171
n
172
ARG
171
A
VAL
172
n
173
VAL
172
A
GLU
173
n
174
GLU
173
A
ALA
174
n
175
ALA
174
A
ILE
175
n
176
ILE
175
A
PRO
176
n
177
PRO
176
A
PHE
177
n
178
PHE
177
A
LEU
178
n
179
LEU
178
A
LEU
179
n
180
LEU
179
A
PRO
180
n
181
PRO
180
A
HIS
181
n
182
HIS
181
A
ASP
182
n
183
ASP
182
A
LEU
183
n
184
LEU
183
A
SER
184
n
185
SER
184
A
ASP
185
n
186
ASP
185
A
LEU
186
n
187
LEU
186
A
PHE
187
n
188
PHE
187
A
ALA
188
n
189
ALA
188
A
ALA
189
n
190
ALA
189
A
ALA
190
n
191
ALA
190
A
ALA
191
n
192
ALA
191
A
TRP
192
n
193
TRP
192
A
ARG
193
n
194
ARG
193
A
ARG
194
n
195
ARG
194
A
PRO
195
n
196
PRO
195
A
GLU
196
n
197
GLU
196
A
LEU
197
n
198
LEU
197
A
TYR
198
n
199
TYR
198
A
LEU
199
n
200
LEU
199
A
LYS
200
n
201
LYS
200
A
ALA
201
n
202
ALA
201
A
GLU
202
n
203
GLU
202
A
VAL
203
n
204
VAL
203
A
ARG
204
n
205
ARG
204
A
ALA
205
n
206
ALA
205
A
GLY
206
n
207
GLY
206
A
ILE
207
n
208
ILE
207
A
SER
208
n
209
SER
208
A
SER
209
n
210
SER
209
A
PHE
210
n
211
PHE
210
A
ALA
211
n
212
ALA
211
A
LEU
212
n
213
LEU
212
A
ALA
213
n
214
ALA
213
A
ASN
214
n
215
ASN
214
A
GLN
215
n
216
GLN
215
A
ASP
216
n
217
ASP
216
A
LEU
217
n
218
LEU
217
A
VAL
218
n
219
VAL
218
A
GLU
219
n
220
GLU
219
A
LYS
220
n
221
LYS
220
A
GLY
221
n
222
GLY
221
A
LEU
222
n
223
LEU
222
A
GLU
223
n
224
GLU
223
A
LEU
224
n
225
LEU
224
A
LEU
225
n
226
LEU
225
A
THR
226
n
227
THR
226
A
ALA
227
n
228
ALA
227
A
ASP
228
n
229
ASP
228
A
LEU
229
n
230
LEU
229
A
ASN
230
n
231
ASN
230
A
ASN
231
n
232
ASN
231
A
GLY
232
n
233
GLY
232
A
GLU
233
n
234
GLU
233
A
TRP
234
n
235
TRP
234
A
ILE
235
n
236
ILE
235
A
ARG
236
n
237
ARG
236
A
LYS
237
n
238
LYS
237
A
TYR
238
n
239
TYR
238
A
GLY
239
n
240
GLY
239
A
GLU
240
n
241
GLU
240
A
ILE
241
n
242
ILE
241
A
HIS
242
n
243
HIS
242
A
HIS
243
n
244
HIS
243
A
LEU
244
n
245
LEU
244
A
GLN
245
n
246
GLN
245
A
GLU
246
n
247
GLU
246
A
ILE
247
n
248
ILE
247
A
ASP
248
n
249
ASP
248
A
ILE
249
n
250
ILE
249
A
GLY
250
n
251
GLY
250
A
TYR
251
n
252
TYR
251
A
ARG
252
n
253
ARG
252
A
PHE
253
n
254
PHE
253
A
ILE
254
n
255
ILE
254
A
TYR
255
n
256
TYR
255
A
THR
256
n
257
THR
256
A
THR
257
n
258
THR
257
A
LEU
258
n
259
LEU
258
A
n
260
259
A
n
261
260
A
0.7346
0.1545
0.3869
2.3912
1.9521
2.1391
-0.1113
-0.0292
-0.0441
-0.4589
0.0388
0.0352
-0.2284
-0.1576
0.0725
-0.0409
-0.1336
0.0336
-0.2232
0.0227
-0.2262
refined
46.6820
29.3630
0.3360
X-RAY DIFFRACTION
A
12
A
258
X-RAY DIFFRACTION
1
author_and_software_defined_assembly
PISA
1
monomeric
A
MSE
67
SELENOMETHIONINE
A
MSE
68
MET
A
MSE
116
SELENOMETHIONINE
A
MSE
117
MET
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
PHE
80
A
O
PHE
81
A
N
ALA
60
A
N
ALA
61
A
O
VAL
61
A
O
VAL
62
A
N
ASP
39
A
N
ASP
40
A
N
ALA
38
A
N
ALA
39
A
O
ILE
98
A
O
ILE
99
A
N
VAL
97
A
N
VAL
98
A
O
VAL
126
A
O
VAL
127
A
N
LEU
127
A
N
LEU
128
A
O
ILE
254
A
O
ILE
255
A
O
TYR
255
A
O
TYR
256
A
N
GLU
173
A
N
GLU
174
A
N
LEU
179
A
N
LEU
180
A
O
ILE
247
A
O
ILE
248
1
A
HOH
353
C
HOH
1
A
CD
LYS
33
A
CD
LYS
34
1
Y
1
A
CE
LYS
33
A
CE
LYS
34
1
Y
1
A
NZ
LYS
33
A
NZ
LYS
34
1
Y
1
A
GLY
0
A
GLY
1
1
Y
1
A
MSE
1
A
MSE
2
1
Y
1
A
SER
2
A
SER
3
1
Y
1
A
ILE
3
A
ILE
4
1
Y
1
A
TYR
4
A
TYR
5
1
Y
1
A
ASN
5
A
ASN
6
1
Y
1
A
SER
6
A
SER
7
1
Y
1
A
ILE
7
A
ILE
8
1
Y
1
A
GLY
8
A
GLY
9
1
Y
1
A
LYS
9
A
LYS
10
1
Y
1
A
GLN
10
A
GLN
11
1
Y
1
A
TYR
11
A
TYR
12
1
Y
1
A
ASP
259
A
ASP
260
1
Y
1
A
LYS
260
A
LYS
261
1
Y
1
3.38
0.50
120.30
123.68
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
121
121
121
N
1
-3.29
0.50
120.30
117.01
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
121
121
121
N
1
4.69
0.50
120.30
124.99
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
133
133
133
N
1
-4.68
0.50
120.30
115.62
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
133
133
133
N
1
A
ARG
15
-99.94
57.86
1
A
ASN
86
-150.54
83.55
1
A
ALA
102
-133.40
-34.87
1
A
ARG
121
-93.01
-111.23
1
A
ALA
191
-89.58
31.63
130.54
70.806
47.24
-1.020
-0.510
0.000
-1.020
0.000
1.530
0.955
0.948
1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY.
3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE
INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY
OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75
FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION.
4. EDO MOLECULE FROM THE CRYSTALLIZATION SOLUTION IS MODELED.
0.202
0.182
0.184
2.400
29.761
946
18460
5.100
99.760
1.00
0.50
10.455
0.129
RANDOM
LIKELY RESIDUAL
1
THROUGHOUT
0.00
SAD
0.217
0.172
0.800
0.800
1.200
MAXIMUM LIKELIHOOD WITH PHASES
BABINET MODEL WITH MASK
2.400
29.761
124
2118
4
0
1990
0.017
0.022
2047
0.004
0.020
1371
1.689
1.953
2786
1.422
3.000
3329
4.394
5.000
248
32.885
23.762
101
11.034
15.000
339
16.714
15.000
15
0.096
0.200
315
0.006
0.020
2274
0.002
0.020
432
0.170
0.200
364
0.152
0.200
1419
0.153
0.200
965
0.074
0.200
987
0.127
0.200
108
0.173
0.200
8
0.209
0.200
19
0.075
0.200
9
1.443
2.000
1420
0.179
2.000
498
2.255
4.000
1993
3.653
6.000
912
4.935
8.000
792
0.257
0.235
2.463
72
1269
1341
20
98.310
48.467
2.40
29.761
3EGE
18494
0.109
0.109
1
6.022
8.700
99.800
0.714
2.40
2.46
1.1
7507
1335
0.714
1
5.60
98.70
0.647
2.46
2.53
1.1
8624
1266
0.647
1
6.80
99.90
0.565
2.53
2.60
1.4
11109
1287
0.565
1
8.60
100.00
0.487
2.60
2.68
1.6
11458
1240
0.487
1
9.20
100.00
0.389
2.68
2.77
2.0
11144
1203
0.389
1
9.30
100.00
0.333
2.77
2.87
2.3
10936
1179
0.333
1
9.30
100.00
0.259
2.87
2.98
2.9
10395
1120
0.259
1
9.30
100.00
0.187
2.98
3.10
4.0
10127
1095
0.187
1
9.20
100.00
0.157
3.10
3.24
4.6
9635
1043
0.157
1
9.20
100.00
0.122
3.24
3.39
6.0
9095
988
0.122
1
9.20
100.00
0.095
3.39
3.58
7.6
8849
967
0.095
1
9.20
100.00
0.077
3.58
3.79
9.0
8436
919
0.077
1
9.20
100.00
0.066
3.79
4.06
10.2
7760
854
0.066
1
9.10
100.00
0.064
4.06
4.38
10.1
7111
786
0.064
1
9.00
100.00
0.064
4.38
4.80
9.8
6728
750
0.064
1
9.00
100.00
0.068
4.80
5.37
9.5
6023
680
0.068
1
8.90
100.00
0.069
5.37
6.20
9.4
5279
602
0.069
1
8.80
100.00
0.076
6.20
7.59
8.3
4525
525
0.076
1
8.60
100.00
0.045
7.59
10.73
13.0
3449
414
0.045
1
8.30
100.00
0.044
10.73
29.76
12.0
1788
241
0.044
1
7.40
95.20
refinement
Garib N. Murshudov
garib@ysbl.york.ac.uk
Fortran_77
http://www.ccp4.ac.uk/dist/html/refmac5.html
REFMAC
program
5.2.0019
refinement
P.D. Adams
PDAdams@lbl.gov
C++
http://www.phenix-online.org/
PHENIX
package
phasing
George M. Sheldrick
gsheldr@shelx.uni-ac.gwdg.de
Fortran_77
http://shelx.uni-ac.gwdg.de/SHELX/
SHELX
package
model building
D.C. & J.S. Richardson lab
molprobity@kinemage.biochem.duke.edu
http://kinemage.biochem.duke.edu/molprobity/
MolProbity
package
3beta29
data scaling
Phil R. Evans
pre@mrc-lmb.cam.ac.uk
5/04/2004
Fortran_77
http://www.ccp4.ac.uk/dist/html/scala.html
SCALA
other
3.2.5
data extraction
PDB
help@deposit.rcsb.org
June 11, 2008
C++
http://sw-tools.pdb.org/apps/PDB_EXTRACT/
PDB_EXTRACT
package
3.006
data reduction
MOSFLM
phasing
SHELXD
phasing
autoSHARP
Crystal structure of Putative methyltransferase from antibiotic biosynthesis pathway (YP_324569.1) from ANABAENA VARIABILIS ATCC 29413 at 2.40 A resolution
1
N
N
2
N
N
3
N
N
AUTHORS STATE THAT CRYSTAL PACKING ANALYSIS SUGGESTS THE ASSIGNMENT OF A MONOMER AS THE SIGNIFICANT OLIGOMERIZATION STATE.
A
ASP
18
A
ASP
19
HELX_P
A
ASN
30
A
ASN
31
1
1
13
A
GLY
45
A
GLY
46
HELX_P
A
ASN
53
A
ASN
54
1
2
9
A
SER
64
A
SER
65
HELX_P
A
GLN
70
A
GLN
71
1
3
7
A
ALA
102
A
ALA
103
HELX_P
A
PHE
106
A
PHE
107
5
4
5
A
HIS
108
A
HIS
109
HELX_P
A
ILE
120
A
ILE
121
1
5
13
A
ILE
132
A
ILE
133
HELX_P
A
ALA
135
A
ALA
136
5
6
4
A
ILE
138
A
ILE
139
HELX_P
A
TYR
143
A
TYR
144
5
7
6
A
PHE
144
A
PHE
145
HELX_P
A
ARG
153
A
ARG
154
1
8
10
A
PRO
156
A
PRO
157
HELX_P
A
LYS
169
A
LYS
170
1
9
14
A
ARG
194
A
ARG
195
HELX_P
A
LEU
199
A
LEU
200
5
10
6
A
LYS
200
A
LYS
201
HELX_P
A
GLY
206
A
GLY
207
1
11
7
A
ILE
207
A
ILE
208
HELX_P
A
ALA
213
A
ALA
214
1
12
7
A
ASN
214
A
ASN
215
HELX_P
A
ASN
231
A
ASN
232
1
13
18
A
GLY
232
A
GLY
233
HELX_P
A
GLY
239
A
GLY
240
1
14
8
A
GLU
240
A
GLU
241
HELX_P
A
LEU
244
A
LEU
245
5
15
5
covale
1.345
both
A
VAL
66
A
C
VAL
67
1_555
A
MSE
67
A
N
MSE
68
1_555
covale
1.347
both
A
MSE
67
A
C
MSE
68
1_555
A
ARG
68
A
N
ARG
69
1_555
covale
1.332
both
A
GLU
115
A
C
GLU
116
1_555
A
MSE
116
A
N
MSE
117
1_555
covale
1.335
both
A
MSE
116
A
C
MSE
117
1_555
A
GLN
117
A
N
GLN
118
1_555
TRANSFERASE
YP_324569.1, Putative methyltransferase from antibiotic biosynthesis pathway, Structural Genomics, Joint Center for Structural Genomics, JCSG, Protein Structure Initiative, PSI-2, Methyltransferase domain, TRANSFERASE
Q3M5R2_ANAVT
UNP
1
1
Q3M5R2
MSIYNSIGKQYSQTRVPDIRIVNAIINLLNLPKGSVIADIGAGTGGYSVALANQGLFVYAVEPSIVMRQQAVVHPQVEWF
TGYAENLALPDKSVDGVISILAIHHFSHLEKSFQEMQRIIRDGTIVLLTFDIRLAQRIWLYDYFPFLWEDALRFLPLDEQ
INLLQENTKRRVEAIPFLLPHDLSDLFAAAAWRRPELYLKAEVRAGISSFALANQDLVEKGLELLTADLNNGEWIRKYGE
IHHLQEIDIGYRFIYTTLDK
1
260
3EGE
1
260
Q3M5R2
A
1
2
261
1
expression tag
GLY
0
3EGE
A
Q3M5R2
UNP
1
7
2
parallel
parallel
parallel
parallel
anti-parallel
anti-parallel
anti-parallel
A
VAL
77
A
VAL
78
A
PHE
80
A
PHE
81
A
PHE
57
A
PHE
58
A
VAL
61
A
VAL
62
A
VAL
36
A
VAL
37
A
ILE
40
A
ILE
41
A
GLY
96
A
GLY
97
A
ILE
100
A
ILE
101
A
ILE
125
A
ILE
126
A
PHE
130
A
PHE
131
A
TYR
251
A
TYR
252
A
THR
257
A
THR
258
A
ARG
171
A
ARG
172
A
PRO
176
A
PRO
177
A
LEU
179
A
LEU
180
A
PRO
180
A
PRO
181
A
GLU
246
A
GLU
247
A
ILE
247
A
ILE
248
BINDING SITE FOR RESIDUE EDO A 261
A
EDO
261
Software
3
A
GLY
41
A
GLY
42
3
1_555
A
GLU
62
A
GLU
63
3
1_555
A
HOH
279
C
HOH
3
1_555
152
P 31 2 1